Quantitative Fecal Immunochemical Test for Detection of Colorectal Cancer and Precancerous Lesions in Sohag

Starting soon

Conditions studied: Colorectal Cancer, Colorectal Adenoma, Sessile Serrated Lesion

In brief

Colorectal cancer is a major cause of cancer-related morbidity and mortality worldwide, and early detection significantly improves patient outcomes. The fecal immunochemical test (FIT) is a non-invasive stool-based test used for detection of colorectal cancer; however, its diagnostic performance varies according to lesion type and anatomical location. This prospective observational cohort study aims to evaluate the diagnostic accuracy of quantitative fecal immunochemical testing (qFIT) in detecting colorectal cancer and precancerous lesions, including advanced adenomas and sessile serrated lesions, in adults undergoing colonoscopy in Sohag Government. The study will assess the sensitivity, specificity, and optimal cutoff values of qFIT according to lesion type, location, and histopathological characteristics.

Key facts

Study ID

NCT07410546

Run by

Sohag University

People needed

150

Starts

2026-02-01

Expected to finish

2026-08-01

Last updated by the study team

2026-02-13

Who can join

Age: any. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Adults aged 40 to 75 years
• Individuals undergoing screening or diagnostic colonoscopy
• Participants able to provide informed consent

You may not qualify if…

• Age below 40 years or above 75 years
• History of colorectal surgery
• Inflammatory bowel disease
• Inadequate bowel preparation
• Refusal to participate

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.